<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6630949\results\search\country\results.xml">
  <result pre="warranted its advancement through phase III and II trials in" exact="Japan" post="and US respectively [112]. Baloxavir marboxil is another antiviral"/>
  <result pre="Baloxavir marboxil is another antiviral which was first developed in" exact="Japan" post="and was shown to act as a selective cap-dependent"/>
  <result pre="drug that had previously been licensed for use in both" exact="China" post="and Russia, for almost several decades [116,117]. It was"/>
  <result pre="Currently, phase III trial of the Arbidol in ongoing in" exact="China" post="and the drug is also due phase IV trial"/>
  <result pre="grant (ACE02-WACCBIP: Awandare). Erasmus Kotey was also supported by the" exact="United States" post="Naval Medical Research Unit 3 via the Globe Project"/>
  <result pre="of antigenic driftVaccine2007256852686210.1016/j.vaccine.2007.07.02717719149 10.SkehelJ.J.StevensD.J.DanielsR.S.DouglasA.R.KnossowM.WilsonI.A.WileyD.C.A carbohydrate side chain on hemagglutinins of" exact="Hong Kong" post="influenza viruses inhibits recognition by a monoclonal antibodyProc. Natl."/>
  <result pre="Small molecule inhibitor of influenza A virus PB2 III recruiting" exact="Belgium" post="T705 (Favipiravir) RNA-dependent RNA polymerase inhibitor IV Japan Baloxavir"/>
  <result pre="III recruiting Belgium T705 (Favipiravir) RNA-dependent RNA polymerase inhibitor IV" exact="Japan" post="Baloxavir marboxil Small molecule inhibitor of cap-dependent endonuclease (PA)"/>
  <result pre="of cap-dependent endonuclease (PA) III recruiting children &amp;lt;1 year 1" exact="Japan" post="Arbidol (Umifenovir) HA resistance to conformational changes triggered by"/>
 </snippets>
</snippetsTree>
